Skip to main content

Woys James's Form 4 filing

Molina Healthcare, Inc. (MOH) · filed May 24, 2024

Accession no.
0001179929-24-000095
Filed
May 24, 2024
Trade date
May 22, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions. Open-market sales total $3.45M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Woys JamesCIK 0001213947Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 22, 2024Common StockSSaleDisposed−750$343.02F2−$257,26562,863Direct
May 22, 2024Common StockSSaleDisposed−1,450$344.32F3−$499,26461,413Direct
May 22, 2024Common StockSSaleDisposed−5,607$345.19F4−$1,935,480.3355,806Direct
May 22, 2024Common StockSSaleDisposed−1,743$346.07F5−$603,200.0154,063Direct
May 22, 2024Common StockSSaleDisposed−350$347.08F6−$121,47853,713Direct
May 22, 2024Common StockSSaleDisposed−100$347.93F7−$34,79353,613Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $342.61 to $343.46. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $343.64 to $344.62. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $344.69 to $345.68. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $345.70 to $346.70. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $346.74 to $347.58. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $347.92 to $347.93. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)